Role of individualized intervention(s) on quality of life and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer: MyCHOICE study
Shahid Ahmed(Emory University), Amer Sami(University of Saskatchewan), Ambika Chandrasekhar(Saskatchewan Cancer Agency), Ayesha Bashir(Saskatchewan Cancer Agency), Mita Manna(Saskatchewan Cancer Agency), Haji Ibrahim Chalchal(Saskatchewan Cancer Agency), Nayyer Iqbal(University of Saskatchewan), Lynn Dwernychuk(Saskatchewan Cancer Agency), Donelda Gowan Leverick(University of Saskatchewan), Wardah Mahmood(University of Saskatchewan), Sonya Mannala(University of Saskatchewan), Prosanta Mondal(University of Saskatchewan), Saija Kontulainen (4431586)(University of Saskatchewan), Osama Ahmed(University of Saskatchewan), Kamal Haider(University of Saskatchewan), Muhammad Salim(University of Saskatchewan), Anne Leis(Saskatchewan Health Authority), Muhammad Imtiaz Khan(Abbottabad University of Science and Technology)
Cited by 0
Related Papers
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
HER2-directed therapy: current treatment options for HER2-positive breast cancer
|Breast Cancer|2015|183
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
|Cancers|2021|183
Current status of immunotherapy in metastatic colorectal cancer
|International Journal of Colorectal Disease|2018|149